We also explored the effect of tp53M214K mutation, which is a loss-of-function in the DNA-binding domain (Berghmans et al, 2005), in the sbds mutant backgrounds, and determined that Tp53 inactivation is not sufficient for their survival or neutropenia. The gene discussed is TP53; the disease is neutropenia.